文献速递支持与姑息治疗

儿童急性淋巴细胞白血病治疗期间感染相关并发症

Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
PubMed 文献 · Ann Oncol · 2017-01-01

该研究评估了409例新诊断儿童急性淋巴细胞白血病(ALL)患者整个治疗期间≥3级感染相关并发症及其危险因素。共2420次感染事件中,发热性中性粒细胞减少1107次,临床或微生物学确诊感染1313次;感染相关死亡3年累积发生率为1.0±0.9%(n=4)。年龄1-9.9岁、白人种族、强化化疗及地塞米松后中性粒细胞未升高与感染相关并发症相关。

要点

  • 409例新诊断ALL患儿中,发热性中性粒细胞减少1107次,确诊感染1313次。
  • 感染相关死亡3年累积发生率为1.0±0.9%(n=4),无真菌感染相关死亡。
  • 年龄1-9.9岁、白人种族、强化化疗及地塞米松后中性粒细胞未升高与感染相关并发症相关。

核心结论

  • 感染相关死亡发生率低,但年龄小、白人种族、强化化疗及地塞米松治疗后中性粒细胞未升高与感染相关并发症相关。
  • 作者认为对这些患者应考虑密切监测以及时给予抗生素并调整化疗。

研究设计与样本

  • 研究评估了409例新诊断儿童急性淋巴细胞白血病(ALL)患者整个治疗期间按美国国家癌症研究所不良事件通用术语标准(版本3.0)评定的≥3级感染相关并发症及其危险因素。

主要发现

  • 2420次感染事件中,发热性中性粒细胞减少1107次,临床或微生物学确诊感染1313次。
  • 确诊感染事件中,上呼吸道最常见(n=389),其次为耳部(n=151)、血流(n=147)和胃肠道(n=145)感染。
  • 感染事件在缓解诱导和再诱导等强化治疗阶段更常见,但呼吸道和耳部感染(推测为病毒性)也发生在维持治疗阶段。
  • 感染相关死亡3年累积发生率为1.0±0.9%(n=4),其中2例死于蜡样芽孢杆菌(Bacillus cereus)菌血症;无真菌感染相关死亡。
  • 诊断时年龄1-9.9岁与诱导期发热性中性粒细胞减少相关(P=0.002),并与后续维持期发热性中性粒细胞减少和确诊感染相关(均P<0.001);白人种族与诱导期确诊感染相关(P=0.034)。

临床怎么用

  • 作者认为对年龄小、白人种族、接受强化化疗及地塞米松治疗后中性粒细胞未升高的患者,应考虑密切监测以及时给予抗生素并调整化疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comprehensive studies on neutropenia and infection-related complications in patients with acute lymphoblastic leukemia (ALL) are lacking. PATIENTS AND METHODS: We evaluated infection-related complications that were grade ≥3 on National Cancer Institute's Common Terminology Criteria for Adverse Events (version 3.0) and their risk factors in 409 children with newly diagnosed ALL throughout the treatment period. RESULTS: Of the 2420 infection episodes, febrile neutropenia and clinically or microbiologically documented infection were seen in 1107 and 1313 episodes, respectively. Among documented infection episodes, upper respiratory tract was the most common site (n = 389), followed by ear (n = 151), bloodstream (n = 147), and gastrointestinal tract (n = 145) infections. These episodes were more common during intensified therapy phases such as remission induction and reinduction, but respiratory and ear infections, presumably viral in origin, also occurred during continuation phases. The 3-year cumulative incidence of infection-related death was low (1.0±0.9%, n = 4), including 2 from Bacillus cereus bacteremia. There was no fungal infection-related mortality. Age 1-9.9 years at diagnosis was associated with febrile neutropenia (P = 0.002) during induction and febrile neutropenia and documented infection (both P < 0.001) during later continuation. White race was associated with documented infection (P = 0.034) during induction. Compared with low-risk patients, standard- and high-risk patients received more intensive therapy during early continuation and had higher incidences of febrile neutropenia (P < 0.001) and documented infections (P = 0.043). Furthermore, poor neutrophil surge after dexamethasone pulses during continuation, which can reflect the poor bone marrow reserve, was associated with infections (P < 0.001). CONCLUSIONS: The incidence of infection-related death was low. However, young age, white race, intensive chemotherapy, and lack of neutrophil surge after dexamethasone treatment were associated with infection-related complications. Close monitoring for prompt administration of antibiotics and modification of chemotherapy should be considered in these patients.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Inaba H, Pei D, Wolf J, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017. PMID: 28426102. doi:10.1093/annonc/mdw557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。